US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 2.3200
  • -0.1400-5.69%
Close Dec 13 16:00 ET
  • 2.1800
  • -0.1400-6.03%
Post 20:01 ET
6.96MMarket Cap-0.19P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.98%7.14M
-3.53%6.19M
-20.07%6.68M
-3.29%29.63M
26.55%8.92M
-34.53%5.95M
-13.76%6.41M
18.09%8.35M
33.40%30.64M
35.41%7.05M
Selling and administrative expenses
-17.57%2.17M
-17.17%2.06M
-9.25%2.39M
-13.21%10.02M
-20.65%2.25M
-14.64%2.64M
-22.03%2.49M
8.88%2.64M
37.63%11.54M
42.47%2.84M
-General and administrative expense
-17.57%2.17M
-17.17%2.06M
-9.25%2.39M
-13.21%10.02M
-20.65%2.25M
-14.64%2.64M
-22.03%2.49M
8.88%2.64M
37.63%11.54M
42.47%2.84M
Research and development costs
50.37%4.93M
5.20%4.09M
-25.23%4.25M
2.74%19.49M
58.74%6.63M
-45.01%3.28M
-7.52%3.89M
23.10%5.69M
31.56%18.97M
31.42%4.18M
Depreciation amortization depletion
-3.13%31K
0.00%31K
6.67%32K
-2.31%127K
9.38%35K
0.00%32K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-Depreciation and amortization
-3.13%31K
0.00%31K
6.67%32K
-2.31%127K
9.38%35K
0.00%32K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
Operating profit
-19.98%-7.14M
3.53%-6.19M
20.07%-6.68M
3.29%-29.63M
-26.55%-8.92M
34.53%-5.95M
13.76%-6.41M
-18.09%-8.35M
-33.40%-30.64M
-35.41%-7.05M
Net non-operating interest income expense
-68.52%102K
-59.23%159K
-38.52%241K
470.00%1.37M
107.94%262K
881.82%324K
900.00%390K
833.33%392K
-21.57%240K
80.00%126K
Non-operating interest income
-68.52%102K
-59.23%159K
-38.52%241K
470.00%1.37M
107.94%262K
881.82%324K
900.00%390K
833.33%392K
-21.57%240K
--126K
Other net income (expense)
-25,521.43%-3.56M
3,693.33%1.71M
3,019.15%1.47M
-209.53%-1.51M
-1,160.53%-1.61M
-96.82%14K
-92.72%45K
-71.52%47K
-79.68%1.38M
-93.42%152K
Gain on sale of security
-172,900.00%-1.73M
4,611.11%1.7M
3,630.77%1.46M
-178.20%-1.04M
-841.72%-1.12M
-99.76%1K
-94.03%36K
-75.63%39K
-80.16%1.34M
-93.43%151K
Other non- operating income (expenses)
-14,184.62%-1.83M
22.22%11K
37.50%11K
-1,255.00%-462K
-49,300.00%-492K
-31.58%13K
-40.00%9K
60.00%8K
0.00%40K
-90.00%1K
Income before tax
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
Income tax
Net income
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
Net income continuous Operations
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
Minority interest income
Net income attributable to the parent company
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-88.84%-10.59M
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
Basic earnings per share
-1.06%-2.85
43.71%-1.7
51.09%-2.02
0.99%-15.1454
-44.75%-5.2054
37.33%-2.82
16.11%-3.02
-14.72%-4.13
-72.84%-15.2961
-166.38%-3.5961
Diluted earnings per share
-1.06%-2.85
43.71%-1.7
51.09%-2.02
0.99%-15.1454
-44.75%-5.2054
37.33%-2.82
16.11%-3.02
-14.72%-4.13
-72.84%-15.2961
-166.38%-3.5961
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.98%7.14M-3.53%6.19M-20.07%6.68M-3.29%29.63M26.55%8.92M-34.53%5.95M-13.76%6.41M18.09%8.35M33.40%30.64M35.41%7.05M
Selling and administrative expenses -17.57%2.17M-17.17%2.06M-9.25%2.39M-13.21%10.02M-20.65%2.25M-14.64%2.64M-22.03%2.49M8.88%2.64M37.63%11.54M42.47%2.84M
-General and administrative expense -17.57%2.17M-17.17%2.06M-9.25%2.39M-13.21%10.02M-20.65%2.25M-14.64%2.64M-22.03%2.49M8.88%2.64M37.63%11.54M42.47%2.84M
Research and development costs 50.37%4.93M5.20%4.09M-25.23%4.25M2.74%19.49M58.74%6.63M-45.01%3.28M-7.52%3.89M23.10%5.69M31.56%18.97M31.42%4.18M
Depreciation amortization depletion -3.13%31K0.00%31K6.67%32K-2.31%127K9.38%35K0.00%32K-8.82%31K-6.25%30K-20.73%130K-5.88%32K
-Depreciation and amortization -3.13%31K0.00%31K6.67%32K-2.31%127K9.38%35K0.00%32K-8.82%31K-6.25%30K-20.73%130K-5.88%32K
Operating profit -19.98%-7.14M3.53%-6.19M20.07%-6.68M3.29%-29.63M-26.55%-8.92M34.53%-5.95M13.76%-6.41M-18.09%-8.35M-33.40%-30.64M-35.41%-7.05M
Net non-operating interest income expense -68.52%102K-59.23%159K-38.52%241K470.00%1.37M107.94%262K881.82%324K900.00%390K833.33%392K-21.57%240K80.00%126K
Non-operating interest income -68.52%102K-59.23%159K-38.52%241K470.00%1.37M107.94%262K881.82%324K900.00%390K833.33%392K-21.57%240K--126K
Other net income (expense) -25,521.43%-3.56M3,693.33%1.71M3,019.15%1.47M-209.53%-1.51M-1,160.53%-1.61M-96.82%14K-92.72%45K-71.52%47K-79.68%1.38M-93.42%152K
Gain on sale of security -172,900.00%-1.73M4,611.11%1.7M3,630.77%1.46M-178.20%-1.04M-841.72%-1.12M-99.76%1K-94.03%36K-75.63%39K-80.16%1.34M-93.43%151K
Other non- operating income (expenses) -14,184.62%-1.83M22.22%11K37.50%11K-1,255.00%-462K-49,300.00%-492K-31.58%13K-40.00%9K60.00%8K0.00%40K-90.00%1K
Income before tax -88.84%-10.59M27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M
Income tax
Net income -88.84%-10.59M27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M
Net income continuous Operations -88.84%-10.59M27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M
Minority interest income
Net income attributable to the parent company -88.84%-10.59M27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -88.84%-10.59M27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M
Basic earnings per share -1.06%-2.8543.71%-1.751.09%-2.020.99%-15.1454-44.75%-5.205437.33%-2.8216.11%-3.02-14.72%-4.13-72.84%-15.2961-166.38%-3.5961
Diluted earnings per share -1.06%-2.8543.71%-1.751.09%-2.020.99%-15.1454-44.75%-5.205437.33%-2.8216.11%-3.02-14.72%-4.13-72.84%-15.2961-166.38%-3.5961
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data